The Neurological Disorder market is a subset of the Neurology field, which focuses on the diagnosis and treatment of disorders of the nervous system. This includes conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. The market is composed of a variety of stakeholders, including pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions. The market is driven by the increasing prevalence of neurological disorders, as well as advances in technology and treatments. Pharmaceutical companies are developing new drugs to treat neurological disorders, while medical device manufacturers are creating innovative products to improve patient care. Healthcare providers are also playing an important role in providing diagnosis and treatment services. Some companies in the Neurological Disorder market include AbbVie, Biogen, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
